Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Skilled nursing providers bracing for yet another audit process should prepare for medical record requests sooner rather than later, especially if the federal government shutdown ends this week as ...

Many of today's performance engines use some form of cylinder deactivation technology to increase fuel economy. When cylinders are deactivated, the engine uses less fuel, but simply "turning off" the ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Distinguishing myelodysplastic syndrome (MDS) from acute myeloid leukemia (AML) solely on the basis of a 20% bone marrow blast cutoff ignores important patient characteristics and genetic factors that ...

There are more treatments today than ever before to help people with ongoing conditions manage their physical symptoms. But even with these medical advances, a diagnosis of myelodysplastic syndromes ...

MDS is a rare form of cancer with its own unique characteristics. Here is one patients perspective on the experience of having MDS. “You have myelodysplastic syndrome,” the oncologist told me soberly.